{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T13:00:54Z","timestamp":1788440454557,"version":"build-2803163510"},"reference-count":73,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":740,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005006","name":"Asan Institute for Life Sciences, Asan Medical Center","doi-asserted-by":"publisher","award":["2016-729"],"award-info":[{"award-number":["2016-729"]}],"id":[{"id":"10.13039\/501100005006","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1038\/s41379-020-0633-x","type":"journal-article","created":{"date-parts":[[2020,7,24]],"date-time":"2020-07-24T12:04:32Z","timestamp":1595592272000},"page":"141-160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Distribution pattern of tumor infiltrating lymphocytes and tumor microenvironment composition as prognostic indicators in anorectal malignant melanoma"],"prefix":"10.1016","volume":"34","author":[{"given":"So-Woon","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Il","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bilal","family":"Mustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi\u2011Ju","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gowun","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Min","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok-Byung","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang Sik","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Cheon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Mo","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In Ja","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/s41379-020-0633-x_bib1","doi-asserted-by":"crossref","first-page":"e5753","DOI":"10.1097\/MD.0000000000005753","article-title":"Clinics, prognosis and new therapeutic options in patients with mucosal melanoma: a retrospective analysis of 75 patients","volume":"96","author":"Schaefer","year":"2017","journal-title":"Medicine"},{"key":"10.1038\/s41379-020-0633-x_bib2","doi-asserted-by":"crossref","first-page":"8785","DOI":"10.18632\/oncotarget.23835","article-title":"Anorectal mucosal melanoma","volume":"9","author":"Malaguarnera","year":"2018","journal-title":"Oncotarget"},{"key":"10.1038\/s41379-020-0633-x_bib3","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/j.1463-1318.2007.01400.x","article-title":"Anorectal amelanotic melanoma","volume":"10","author":"Hillenbrand","year":"2008","journal-title":"Colorectal Dis"},{"key":"10.1038\/s41379-020-0633-x_bib4","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/BF02052442","article-title":"Anorectal melanoma. A 64-year experience at Memorial Sloan-Kettering Cancer Center","volume":"38","author":"Brady","year":"1995","journal-title":"Dis Colon Rectum"},{"key":"10.1038\/s41379-020-0633-x_bib5","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/path.4204","article-title":"Genome sequencing of mucosal melanomas reveals that they are driven by distinct mechanisms from cutaneous melanoma","volume":"230","author":"Furney","year":"2013","journal-title":"J Pathol"},{"key":"10.1038\/s41379-020-0633-x_bib6","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nature22071","article-title":"Whole-genome landscapes of major melanoma subtypes","volume":"545","author":"Hayward","year":"2017","journal-title":"Nature"},{"key":"10.1038\/s41379-020-0633-x_bib7","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/ng.2359","article-title":"Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma","volume":"44","author":"Krauthammer","year":"2012","journal-title":"Nat Genet"},{"key":"10.1038\/s41379-020-0633-x_bib8","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1053\/j.gastro.2004.08.051","article-title":"BRAF mutations distinguish anorectal from cutaneous melanoma at the molecular level","volume":"127","author":"Helmke","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1038\/s41379-020-0633-x_bib9","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.1158\/1078-0432.CCR-03-0562","article-title":"Exon 15 BRAF mutations are uncommon in melanomas arising in nonsun-exposed sites","volume":"10","author":"Cohen","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1038\/s41379-020-0633-x_bib10","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/jmg.2003.016667","article-title":"Absence of BRAF mutations in UV-protected mucosal melanomas","volume":"41","author":"Edwards","year":"2004","journal-title":"J Med Genet"},{"key":"10.1038\/s41379-020-0633-x_bib11","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1093\/jnci\/djg123","article-title":"Determinants of BRAF mutations in primary melanomas","volume":"95","author":"Maldonado","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1038\/s41379-020-0633-x_bib12","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.bcp.2010.03.019","article-title":"BRAF as therapeutic target in melanoma","volume":"80","author":"Wellbrock","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"10.1038\/s41379-020-0633-x_bib13","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1200\/JCO.2010.32.4327","article-title":"Prognostic and clinicopathologic associations of oncogenic BRAF in metastatic melanoma","volume":"29","author":"Long","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1038\/s41379-020-0633-x_bib14","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1200\/JCO.2014.56.2736","article-title":"Pooled analysis of long-term survival data from Phase II and Phase III trials of ipilimumab in unresectable or metastatic melanoma","volume":"33","author":"Schadendorf","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1038\/s41379-020-0633-x_bib15","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1007\/s00268-019-04960-w","article-title":"Treatment strategies and survival trends for anorectal melanoma: is it time for a change?","volume":"43","author":"Taylor","year":"2019","journal-title":"World J Surg"},{"key":"10.1038\/s41379-020-0633-x_bib16","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/codi.13412","article-title":"Extensive surgery and lymphadenectomy do not improve survival in primary melanoma of the anorectum: results from analysis of a large database (SEER)","volume":"19","author":"Ciarrocchi","year":"2017","journal-title":"Colorectal Dis"},{"key":"10.1038\/s41379-020-0633-x_bib17","doi-asserted-by":"crossref","first-page":"Mmt11","DOI":"10.2217\/mmt-2018-0003","article-title":"Combatting mucosal melanoma: recent advances and future perspectives","volume":"5","author":"Tyrrell","year":"2018","journal-title":"Melanoma Manag"},{"key":"10.1038\/s41379-020-0633-x_bib18","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1200\/JCO.2016.67.9258","article-title":"Efficacy and safety of nivolumab alone or in combination with ipilimumab in patients with mucosal melanoma: a pooled analysis","volume":"35","author":"D'Angelo","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1038\/s41379-020-0633-x_bib19","doi-asserted-by":"crossref","first-page":"S118","DOI":"10.21037\/atm.2019.05.62","article-title":"Immunotherapy for mucosal melanoma","volume":"7","author":"Yentz","year":"2019","journal-title":"Ann Transl Med"},{"key":"10.1038\/s41379-020-0633-x_bib20","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s00262-019-02351-7","article-title":"Evaluation of the efficacy of immunotherapy for non-resectable mucosal melanoma","volume":"68","author":"Moya-Plana","year":"2019","journal-title":"Cancer Immunol Immunother"},{"key":"10.1038\/s41379-020-0633-x_bib21","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/labinvest.2017.64","article-title":"Melanoma subtypes demonstrate distinct PD-L1 expression profiles","volume":"97","author":"Kaunitz","year":"2017","journal-title":"Lab Investig"},{"key":"10.1038\/s41379-020-0633-x_bib22","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.pathol.2018.09.060","article-title":"Primary anorectal melanoma: clinical, immunohistology and DNA analysis of 43 cases","volume":"51","author":"Dodds","year":"2019","journal-title":"Pathology"},{"key":"10.1038\/s41379-020-0633-x_bib23","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/DCR.0b013e31827901dd","article-title":"Anal versus rectal melanoma: does site of origin predict outcome?","volume":"56","author":"Bello","year":"2013","journal-title":"Dis Colon Rectum"},{"key":"10.1038\/s41379-020-0633-x_bib24","series-title":"Histology for pathologists.","author":"SE","year":"2012"},{"key":"10.1038\/s41379-020-0633-x_bib25","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/s41379-019-0340-7","article-title":"Prognostic model for patient survival in primary anorectal mucosal melanoma: stage at presentation determines relevance of histopathologic features","volume":"33","author":"Nagarajan","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-020-0633-x_bib26","first-page":"1","article-title":"Prognosis in cutaneous melanoma: tumor thickness as a guide to treatment","volume":"15","author":"Breslow","year":"1980","journal-title":"Pathol Annu"},{"key":"10.1038\/s41379-020-0633-x_bib27","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1093\/jnci\/81.24.1893","article-title":"Model predicting survival in stage I melanoma based on tumor progression","volume":"81","author":"Clark","year":"1989","journal-title":"J Natl Cancer Inst"},{"key":"10.1038\/s41379-020-0633-x_bib28","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1200\/JCO.2010.31.5812","article-title":"Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging database","volume":"29","author":"Thompson","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1038\/s41379-020-0633-x_bib29","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1038\/modpathol.2013.59","article-title":"Immunodetection of phosphohistone H3 as a surrogate of mitotic figure count and clinical outcome in cutaneous melanoma","volume":"26","author":"Tetzlaff","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-020-0633-x_bib30","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1097\/01.pas.0000213262.61855.7d","article-title":"Prognostic significance of extent of ulceration in primary cutaneous melanoma","volume":"30","author":"Grande Sarpa","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-020-0633-x_bib31","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1001\/archderm.137.9.1169","article-title":"Vascular involvement in the prognosis of primary cutaneous melanoma","volume":"137","author":"Kashani-Sabet","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1038\/s41379-020-0633-x_bib32","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1002\/1097-0142(19951201)76:11<2242::AID-CNCR2820761110>3.0.CO;2-I","article-title":"Desmoplasia and neurotropism. Prognostic variables in patients with stage I melanoma","volume":"76","author":"Baer","year":"1995","journal-title":"Cancer"},{"key":"10.1038\/s41379-020-0633-x_bib33","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/978-1-62703-727-3_16","article-title":"Tumor-infiltrating lymphocytes and their significance in melanoma prognosis","volume":"1102","author":"Schatton","year":"2014","journal-title":"Methods Mol Biol"},{"key":"10.1038\/s41379-020-0633-x_bib34","series-title":"WHO classification of tumours of the digestive system","author":"Bosman FT","year":"2018"},{"key":"10.1038\/s41379-020-0633-x_bib35","unstructured":"Amin MB, Edge SB, American Joint Committee on C. AJCC cancer staging manual. 8th ed. New York, NY: Springer; 2017."},{"key":"10.1038\/s41379-020-0633-x_bib36","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0002-9610(70)80001-0","article-title":"Malignant melanoma of the skin of the head and neck. An analysis of 405 cases","volume":"120","author":"Ballantyne","year":"1970","journal-title":"Am J Surg"},{"key":"10.1038\/s41379-020-0633-x_bib37","doi-asserted-by":"crossref","first-page":"24269","DOI":"10.18632\/oncotarget.8169","article-title":"PD-L1 is an independent prognostic predictor in gastric cancer of Western patients","volume":"7","author":"Boger","year":"2016","journal-title":"Oncotarget"},{"key":"10.1038\/s41379-020-0633-x_bib38","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.3324\/haematol.2013.100784","article-title":"Survival analysis in hematologic malignancies: recommendations for clinicians","volume":"99","author":"Delgado","year":"2014","journal-title":"Haematologica"},{"key":"10.1038\/s41379-020-0633-x_bib39","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1182\/blood-2012-03-415588","article-title":"Clinical and prognostic role of annexin A2 in multiple myeloma","volume":"120","author":"Seckinger","year":"2012","journal-title":"Blood"},{"key":"10.1038\/s41379-020-0633-x_bib40","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.18632\/oncotarget.1740","article-title":"A DNA repair pathway score predicts survival in human multiple myeloma: the potential for therapeutic strategy","volume":"5","author":"Kassambara","year":"2014","journal-title":"Oncotarget"},{"key":"10.1038\/s41379-020-0633-x_bib41","doi-asserted-by":"crossref","unstructured":"Hassen W, Kassambara A, Reme T, Sahota S, Seckinger A, Vincent L, et al. Drug metabolism and clearance system in tumor cells of patients with multiple myeloma. Oncotarget. 2015;6:6431\u201347.","DOI":"10.18632\/oncotarget.3237"},{"key":"10.1038\/s41379-020-0633-x_bib42","doi-asserted-by":"crossref","first-page":"5219","DOI":"10.1158\/1078-0432.CCR-18-0741","article-title":"Interim PET analysis in first-line therapy of multiple myeloma: prognostic value of DeltaSUVmax in the FDG-Avid Patients of the IMAJEM Study","volume":"24","author":"Bailly","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1038\/s41379-020-0633-x_bib43","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2967\/jnumed.114.147561","article-title":"Prognostic value of total lesion glycolysis by 18F-FDG PET\/CT in surgically resected stage IA non-small cell lung cancer","volume":"56","author":"Park","year":"2015","journal-title":"J Nucl Med"},{"key":"10.1038\/s41379-020-0633-x_bib44","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.3802\/jgo.2017.28.e43","article-title":"Prognostic value of metabolic parameters determined by preoperative (1)(8)F-FDG PET\/CT in patients with uterine carcinosarcoma","volume":"28","author":"Lee","year":"2017","journal-title":"J Gynecol Oncol"},{"key":"10.1038\/s41379-020-0633-x_bib45","doi-asserted-by":"crossref","first-page":"20160239","DOI":"10.1259\/bjr.20160239","article-title":"Lymph node standardized uptake values at pre-treatment (18)F-fluorodeoxyglucose positron emission tomography as a valuable prognostic factor for distant metastasis in nasopharyngeal carcinoma","volume":"90","author":"Jeong","year":"2017","journal-title":"Br J Radiol"},{"key":"10.1038\/s41379-020-0633-x_bib46","doi-asserted-by":"crossref","unstructured":"Choi YH, Lee SH, You MS, Shin BS, Paik WH, Ryu JK, et al. Prognostic factors for patients with borderline resectable or locally advanced pancreatic cancer receiving Neoadjuvant FOLFIRINOX. Gut Liver. 2020. [Online ahead of print].","DOI":"10.1016\/j.pan.2020.07.275"},{"key":"10.1038\/s41379-020-0633-x_bib47","doi-asserted-by":"crossref","first-page":"8121985","DOI":"10.1155\/2016\/8121985","article-title":"Adjuvant autologous melanoma vaccine for macroscopic Stage III disease: survival, biomarkers, and improved response to CTLA-4 Blockade","volume":"2016","author":"Lotem","year":"2016","journal-title":"J Immunol Res"},{"key":"10.1038\/s41379-020-0633-x_bib48","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1158\/2326-6066.CIR-18-0436","article-title":"Tumor microenvironment characterization in gastric cancer identifies prognostic and immunotherapeutically relevant gene signatures","volume":"7","author":"Zeng","year":"2019","journal-title":"Cancer Immunol Res"},{"key":"10.1038\/s41379-020-0633-x_bib49","unstructured":"Hothorn T, Lausen B. Maxstat: maximally selected rank statistics. R package version 07-21; 2015."},{"key":"10.1038\/s41379-020-0633-x_bib50","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/(SICI)1097-0142(19960401)77:7<1303::AID-CNCR12>3.0.CO;2-5","article-title":"Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma","volume":"77","author":"Clemente","year":"1996","journal-title":"Cancer"},{"key":"10.1038\/s41379-020-0633-x_bib51","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature21349","article-title":"Elements of cancer immunity and the cancer-immune set point","volume":"541","author":"Chen","year":"2017","journal-title":"Nature"},{"key":"10.1038\/s41379-020-0633-x_bib52","doi-asserted-by":"crossref","first-page":"xii18","DOI":"10.1093\/annonc\/mdx238","article-title":"Mechanisms regulating T-cell infiltration and activity in solid tumors","volume":"28","author":"Lanitis","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1038\/s41379-020-0633-x_bib53","doi-asserted-by":"crossref","first-page":"113","DOI":"10.4174\/astr.2014.87.3.113","article-title":"The clinical features and optimal treatment of anorectal malignant melanoma","volume":"87","author":"Nam","year":"2014","journal-title":"Ann Surg Treat Res"},{"key":"10.1038\/s41379-020-0633-x_bib54","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/0016-5085(93)90849-8","article-title":"Epidemiology and prognosis of anorectal melanoma","volume":"104","author":"Weinstock","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1038\/s41379-020-0633-x_bib55","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.humpath.2018.05.004","article-title":"Prognostic factors in primary anorectal melanoma: a clinicopathological study of 60 cases in China","volume":"79","author":"Ren","year":"2018","journal-title":"Hum Pathol"},{"key":"10.1038\/s41379-020-0633-x_bib56","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.coi.2014.01.004","article-title":"New insights into cancer immunoediting and its three component phases\u2013elimination, equilibrium and escape","volume":"27","author":"Mittal","year":"2014","journal-title":"Curr Opin Immunol"},{"key":"10.1038\/s41379-020-0633-x_bib57","doi-asserted-by":"crossref","unstructured":"Kwong LN, De Macedo MP, Haydu L, Joon AY, Tetzlaff MT, Calderone TL, et al. Biological validation of RNA sequencing data from formalin-fixed paraffin-embedded primary melanomas. JCO Prec Oncol. 2018. https:\/\/doi.org\/10.1200\/PO.1217.00259.","DOI":"10.1200\/PO.17.00259"},{"key":"10.1038\/s41379-020-0633-x_bib58","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","article-title":"Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response","volume":"24","author":"Jiang","year":"2018","journal-title":"Nat Med"},{"key":"10.1038\/s41379-020-0633-x_bib59","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/jso.25163","article-title":"Alterations in patient plasma microRNA expression profiles following resection of metastatic melanoma","volume":"118","author":"Latchana","year":"2018","journal-title":"J Surg Oncol"},{"key":"10.1038\/s41379-020-0633-x_bib60","doi-asserted-by":"crossref","first-page":"108786","DOI":"10.18632\/oncotarget.22150","article-title":"Transcriptional response to hypoxic stress in melanoma and prognostic potential of GBE1 and BNIP3","volume":"8","author":"Buart","year":"2017","journal-title":"Oncotarget"},{"key":"10.1038\/s41379-020-0633-x_bib61","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1158\/2326-6066.CIR-17-0360","article-title":"Quantitative analysis of immune infiltrates in primary melanoma","volume":"6","author":"Gartrell","year":"2018","journal-title":"Cancer Immunol Res"},{"key":"10.1038\/s41379-020-0633-x_bib62","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1158\/1078-0432.CCR-18-2847","article-title":"Validation of Melanoma Immune Profile (MIP), a prognostic immune gene prediction score for Stage II-III melanoma","volume":"25","author":"Gartrell","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1038\/s41379-020-0633-x_bib63","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1200\/JCO.2011.37.8539","article-title":"Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma","volume":"30","author":"Azimi","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1038\/s41379-020-0633-x_bib64","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/ni.2703","article-title":"Innate and adaptive immune cells in the tumor microenvironment","volume":"14","author":"Gajewski","year":"2013","journal-title":"Nat Immunol"},{"key":"10.1038\/s41379-020-0633-x_bib65","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.3389\/fonc.2019.01148","article-title":"Immune system evasion as Hallmark of melanoma progression: the role of dendritic cells","volume":"9","author":"Tucci","year":"2019","journal-title":"Front Oncol"},{"key":"10.1038\/s41379-020-0633-x_bib66","doi-asserted-by":"crossref","unstructured":"Kather JN, Suarez-Carmona M, Charoentong P, Weis CA, Hirsch D, Bankhead P, et al. Topography of cancer-associated immune cells in human solid tumors. Elife. 2018;7:e36967.","DOI":"10.7554\/eLife.36967"},{"key":"10.1038\/s41379-020-0633-x_bib67","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/PAP.0000000000000161","volume":"24","author":"Hendry","year":"2017","journal-title":"Adv Anat Pathol"},{"key":"10.1038\/s41379-020-0633-x_bib68","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","article-title":"Regulatory T cells and immune tolerance","volume":"133","author":"Sakaguchi","year":"2008","journal-title":"Cell"},{"key":"10.1038\/s41379-020-0633-x_bib69","doi-asserted-by":"crossref","first-page":"1593806","DOI":"10.1080\/2162402X.2019.1593806","article-title":"Prognostic value of tumor-infiltrating lymphocytes in melanoma: a systematic review and meta-analysis","volume":"8","author":"Fu","year":"2019","journal-title":"Oncoimmunology"},{"key":"10.1038\/s41379-020-0633-x_bib70","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1002\/cncr.24999","article-title":"Intratumoral forkhead box P3-positive regulatory T cells predict poor survival in cyclooxygenase-2-positive uveal melanoma","volume":"116","author":"Mougiakakos","year":"2010","journal-title":"Cancer"},{"key":"10.1038\/s41379-020-0633-x_bib71","first-page":"223","article-title":"Infiltrative T regulatory cells in enucleated uveal melanomas","volume":"107","author":"Lagouros","year":"2009","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1038\/s41379-020-0633-x_bib72","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1600-0625.2011.01260.x","article-title":"Prognostic value of tumor-infiltrating Foxp3+ T-cell subpopulations in metastatic melanoma","volume":"20","author":"Knol","year":"2011","journal-title":"Exp Dermatol"},{"key":"10.1038\/s41379-020-0633-x_bib73","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00262-017-2072-1","article-title":"Tumor-infiltrating immune cells as potential biomarkers predicting response to treatment and survival in patients with metastatic melanoma receiving ipilimumab therapy","volume":"67","author":"Balatoni","year":"2018","journal-title":"Cancer Immunol Immunother"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41379-020-0633-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41379-020-0633-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222004021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222004021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41379-020-0633-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:34:14Z","timestamp":1760229254000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222004021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":73,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0893395222004021"],"URL":"https:\/\/doi.org\/10.1038\/s41379-020-0633-x","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Distribution pattern of tumor infiltrating lymphocytes and tumor microenvironment composition as prognostic indicators in anorectal malignant melanoma","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41379-020-0633-x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}